Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease

Supplementary Data

Supplementary Data

• Supplementary Data - Docx file
• Supplementary Figure 1 - tif file
• Supplementary Figure 2 - tif file
• Supplementary Figure 3 - tif file
• Supplementary Figure 4 - tif file
• Supplementary Figure 5 - tif file
• Supplementary Video 1a - avi file
• Supplementary Video 1b - avi file
• Supplementary Video 2a - avi file
• Supplementary Video 2b - avi file
• Supplementary Video 3 - avi file
• Supplementary Video 4a - mov file
• Supplementary Video 4b - mov file
• Supplementary Video 4c - mov file
• Supplementary Video 4d - mov file